GlaxoSmithKline SAE operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline SAE with three other
companies in this sector in EGYPT :
Egyptian International Pharmaceuticals Industries Co SAE
sales of 2.91 billion Egyptian Pounds [US$185.70 million]
of which 100%
Memphis Pharmaceuticals and Chemical Industries SAE
(490.10 million Egyptian Pounds [US$31.28 million]
Alexandria Company for Pharmaceuticals and Chemical Industries SAE
(1.02 billion Egyptian Pounds [US$65.40 million]
During the year ended December of 2020, sales at
GlaxoSmithKline SAE were 1.99 billion Egyptian Pounds (US$127.18 million).
increase of 16.9%
versus 2019, when the company's sales were 1.70 billion Egyptian Pounds.
This was the fifth consecutive year of sales increases at GlaxoSmithKline SAE
(and since 2015, sales have increased a total of 95%).
Sales of Consumer Care Sector saw an increase
that was more than double the company's growth rate: sales were up
97.3% in 2020, from
326.53 million Egyptian Pounds to 644.14 million Egyptian Pounds.
Not all segments of GlaxoSmithKline SAE experienced an increase in sales in 2020:
sales of Medical Sector fell 2.1% to 1.35 billion Egyptian Pounds.